Skip to main content

Bard Hernia Mesh MDL Might Have 3,000 Claims By The Year-End

Bard Hernia Mesh MDL Might Have 3,000 Claims By The Year-End

Bard Hernia Mesh MDL Might Have 3,000 Claims By The Year-End

Introduction

In a status conference held last week, Judge Edmund A. Sargus, overlooking the Bard hernia mesh MDL, issued a pretrial order, which included a prediction made by plaintiff lawyers that roughly 3,000 claims would be filed in the federal MDL by the end of 2019.

Judge Sargus had previously allowed the direct filing of claims into the federal MDL to streamline the process. In a separate case management order issued on March 8, Judge Sargus outlined the form procedure and schedule for 12 plaintiffs who were selected for the bellwether pool to complete Plaintiff Fact Sheets (PFS), to be submitted by March 25, 2019. The next status conference has been scheduled for April 17, 2019, where the parties will meet the court to discuss further proceedings. Bellwether trials will probably begin on May 8,  July 13, and September 14, next year, when the parties will observe how the jury will respond to certain evidence and testimony which will be repeated throughout the litigation.

Bard hernia mesh lawsuits, filed over complaints of debilitating complications caused due to defective mesh design, are centralized in the Southern District of Ohio as part of multidistrict litigation (MDL No. 2846; In Re:  Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation) for coordinated pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!